Difficulties in the Management of Placenta Accreta Spectrum in Hospitals with Limited Resources

Abstract

Objective Placenta accreta spectrum (PAS) is a serious diseases, and the recommendation is that the treatment is conducted in centers of excellence. Such hospitals are not easy to find in low- and middle-income countries. We seek to describe the process of prenatal diagnosis, surgical management, and postnatal histological analysis in a low-income country referral hospital with limited resources.

Methods A descriptive, retrospective study was carried out including patients with a pre- or intraoperative diagnosis of PAS. The clinical results of the patients were studied as well as the results of the prenatal ultrasound and the correlation with the postnatal pathological diagnosis.

Results In total, 129 patients were included. Forty-eight of them had a prenatal PAS ultrasound diagnosis (37.2%). In the remaining 81 (62.8%), the diagnosis was intraoperative.

Although hysterectomy was performed in all cases, one-third of the patients (31%) did not have a histological study of the uterus. In 40% of the patients who had a histological study, PAS was not reported by the pathologist.

Conclusion The frequency of prenatal diagnosis and the availability of postnatal histological studies were very low in the studied population. Surgical skill, favored by a high flow of patients, is an important factor to avoid complications in settings with limited resources.

Resumo

Objetivo O espectro da placenta accreta é uma patologia grave, cujo tratamento é recomendado em centros de excelência. Esses hospitais não são fáceis de encontrar em países de baixa e média renda. Procuramos descrever o processo de diagnóstico pré-natal, tratamento cirúrgico, e análise histológica pós-natal em um hospital de referência de baixa renda com recursos limitados.

Métodos Foi realizado um estudo descritivo, retrospectivo, incluindo pacientes com diagnóstico pré ou intraoperatório de espectro da placenta accreta. Foram estudados os resultados clínicos das pacientes, bem como os resultados da ultrassonografia pré-natal e a correlação com o diagnóstico patológico pós-natal.

Resultados No total, 129 pacientes foram incluídas. Quarenta e oito delas tiveram um diagnóstico de ultrassom do espectro da placenta accreta pré-natal (37,2%). Nos 81 (62,8%) restantes, o diagnóstico foi intraoperatório.

Embora a histerectomia tenha sido realizada em todos os casos, um terço deles (31%) não tinha estudo histológico do útero. Em 40% dos pacientes que tiveram estudo histológico, o espectro da placenta accreta não foi relatado pelo patologista.

Conclusão A frequência do diagnóstico pré-natal e a disponibilidade de estudos histológicos pós-natais foram muito baixas na população estudada. A habilidade cirúrgica, favorecida por um alto fluxo de pacientes, é um fator importante para evitar complicações em ambientes com recursos limitados.

Keywords

placenta accreta - developing countries - Latin America

Palavras-chave

placenta accreta - países em desenvolvimento - América Latina

Contributors

All authors contributed with the project and data interpretation, the writing of the article, the critical review of the intellectual content, and with the final approval of the version to be published.

Publication History

Received: 05 October 2021

Accepted: 13 December 2021

Article published online:
26 April 2022

• References

• 1 Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet 2018; 140 (03) 281-290 DOI: 10.1002/ijgo.12409.
• 2 Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK. et al. Center of excellence for placenta accreta. Am J Obstet Gynecol 2015; 212 (05) 561-568 DOI: 10.1016/j.ajog.2014.11.018.
• 3 Nieto-Calvache AJ, López-Girón MC, Nieto-Calvache A, Messa-Bryon A, Benavides-Calvache JP, Burgos-Luna JM. A nationwide survey of centers with multidisciplinary teams for placenta accreta patient care in Colombia, observational study. J Matern Fetal Neonatal Med 2020; •••: 1-7 DOI: 10.1080/14767058.2020.1786052. [ahead of print]
• 4 Nieto-Calvache AJ, Palacios-Jaraquemada JM, Hidalgo A, Vergara-Galliadi LM, Cortés Charry R, Aguilera Daga LR. et al. Management practices for placenta accreta spectrum patients: a Latin American hospital survey. J Matern Fetal Neonatal Med 2021; •••: 1-8 DOI: 10.1080/14767058.2021.1906858. [ahead of print]
• 5 Nieto-Calvache AJ, Palacios-Jaraquemada JM, Osanan G, Cortes-Charry R, Aryananda RA, Bangal VB. et al; Latin American group for the study of placenta accreta spectrum. Lack of experience is a main cause of maternal death in placenta accreta spectrum patients. Acta Obstet Gynecol Scand 2021; 100 (08) 1445-1453 DOI: 10.1111/aogs.14163.
• 6 Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019; 146 (01) 20-24 DOI: 10.1002/ijgo.12761.
• 7 Sargent W, Collins SL. Are women antenatally diagnosed with abnormally invasive placenta receiving optimal management in England? An observational study of planned place of delivery. Acta Obstet Gynecol Scand 2019; 98 (03) 337-341 DOI: 10.1111/aogs.13487.
• 8 Matsubara S. Re: Moving from intrapartum to prenatal diagnosis of placenta accreta: a quarter of a century in the making but still a long way to go: Obstetricians' intra-surgical ‘eyes’ keep on shining. BJOG 2017; 124 (08) 1287-1288 DOI: 10.1111/1471-0528.14568.
• 9 Dannheim K, Shainker SA, Hecht JL. Hysterectomy for placenta accreta; methods for gross and microscopic pathology examination. Arch Gynecol Obstet 2016; 293 (05) 951-958 DOI: 10.1007/s00404-015-4006-5.
• 10 Nieto-Calvache AJ, López-Girón MC, Messa-Bryon A, Ceballos-Posada ML, Duque-Galán M, Ríos-Posada JG. et al. Urinary tract injuries during treatment of patients with morbidly adherent placenta. J Matern Fetal Neonatal Med 2021; 34 (19) 3140-3146 DOI: 10.1080/14767058.2019.1678135.
• 11 Shamshirsaz AA, Fox KA, Erfani H, Clark SL, Salmanian B, Baker BW. et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol 2017; 216 (06) 612.e1-612.e5 DOI: 10.1016/j.ajog.2017.02.016.
• 12 Shamshirsaz AA, Fox KA, Erfani H, Belfort MA. The role of centers of excellence with multidisciplinary teams in the management of abnormal invasive placenta. Clin Obstet Gynecol 2018; 61 (04) 841-850 DOI: 10.1097/GRF.0000000000000393.
• 13 Instituto Nacional de Estadística. Bolivia: población estimada y proyectada por departamento, según años calendario, 2012-2022 [Internet]. 2020 [cited 2021 Jan 19]. Available from: https://www.ine.gob.bo/index.php/censos-y-proyecciones-de-poblacion-sociales
• 14 Jauniaux E, Hussein AM, Zosmer N, Elbarmelgy RM, Elbarmelgy RA, Shaikh H. et al. A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta. Am J Obstet Gynecol 2020; 222 (04) 379.e1-379.e11 DOI: 10.1016/j.ajog.2019.11.1246.
• 15 Nieto-Calvache AJ, Zambrano MA, Herrera NA, Usma A, Bryon AM, Benavides Calvache JP. et al. Resective-reconstructive treatment of abnormally invasive placenta: Inter Institutional Collaboration by telemedicine (eHealth). J Matern Fetal Neonatal Med 2021; 34 (05) 765-773 DOI: 10.1080/14767058.2019.1615877.